Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

fulranumab

A fully human monoclonal antibody directed against nerve growth factor (NGF) with potential analgesic activity. Upon administration, fulranumab binds… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BackgroundThis study was designed to evaluate the efficacy and safety of fulranumab, a fully human monoclonal antibody directed… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
2017
2017
To evaluate the long‐term safety and efficacy of fulranumab in patients with knee or hip pain caused by moderate‐to‐severe… Expand
2017
2017
Objective: Fulranumab is an antibody that specifically neutralizes the biological activity of human nerve growth factor. This… Expand
Review
2016
Review
2016
There continues to be an unmet need for safe and effective pain medications. Opioids and nonsteroidal anti-inflammatory drugs… Expand
  • figure 1
  • table 2
2016
2016
The efficacy and safety of monotherapy with fulranumab, a monoclonal antibody that neutralises human nerve growth factor (NGF… Expand
2014
2014
Fulranumab, a human IgG2 monoclonal antibody that neutralizes nerve growth factor (NGF), is currently in development for the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Objective: To assess efficacy and safety of fulranumab, a fully human monoclonal antibody against nerve growth factor, in… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 2
2013
2013
Summary Fulranumab, a new class of analgesic therapy, was safe and efficacious in a randomized, double‐blind, placebo‐controlled… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2013
2013
OBJECTIVE: To evaluate analgesic efficacy of fulranumab, a human recombinant investigational anti-nerve growth factor (NGF… Expand
2011
2011
Nerve growth factor (NGF) is increased in chronic pain conditions. This study examined analgesic efficacy and safety of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3